References
- American Lung AssociationChronic obstructive pulmonary disease (COPD) fact sheet2014 Available from: http://www.lung.org/lung-disease/copd/resources/facts-figures/COPD-Fact-Sheet.html#note_12Accessed May 4, 2014
- XuJQKochanekKDMurphySLTejada-VeraBDeaths: Final Data for 2007Natl Vital Stat Rep2010581136
- global initiative for chronic Obstructive Lung Disease (GOLD)Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Pulmonary DiseaseBethesda (MD)GOLD2011
- AstraZenecaSymbicort inhalation aerosol [package insert]LondonAstraZeneca2009
- Boehringer IngelheimSpiriva HandiHaler [package insert]Ingelheim, GermanyBoehringer Ingelheim2012
- ManninoDMHomaDMAkinbamiLJFordESReddSCChronic obstructive pulmonary disease surveillance – United States, 1971–2000Respir Care2002471184119912354338
- ClarkBTGarcia-TsaoGFraenkelLPatterns and predictors of treatment initiation and completion in patients with chronic hepatitis C virus infectionPatient Prefer Adherence2012628529522536063
- HalavaHHelin-SalmivaaraAJunnilaJHuupponenRSelective prescribing of simvastatin and atorvastatin by patient characteristics at treatment initiation over a 7-year period in FinlandEur J Clin Pharmacol20096592793319471912
- MitraDTraskPCIyerSCandrilliSDKayeJAPatient characteristics and treatment patterns in chronic myeloid leukemia: evidence from a multi-country retrospective medical record chart review studyInt J Hematol20129526327322351162
- AbudaggaASunSXTanHSolemCTExacerbations among chronic bronchitis patients treated with maintenance medications from a US managed care population: an administrative claims data analysisInt J Chron Obstruct Pulmon Dis2013817518523589684
- AbudaggaASunSXTanHSolemCTHealthcare utilization and costs among chronic bronchitis patients treated with maintenance medications from a US managed care populationJ Med Econ20131642142923336296
- DalalAARobertsMHPetersenHVBlanchetteCMMapelDWComparative cost-effectiveness of a fluticasone-propionate/salmeterol combination versus anticholinergics as initial maintenance therapy for chronic obstructive pulmonary diseaseInt J Chron Obstruct Pulmon Dis20116132221311689
- HurstJRVestboJAnzuetoASusceptibility to exacerbation in chronic obstructive pulmonary diseaseN Engl J Med20103631128113820843247
- ThomsenMIngebrigtsenTSMarottJLInflammatory biomarkers and exacerbations in chronic obstructive pulmonary diseaseJAMA20133092353236123757083
- BlaisLForgetARamachandranSRelative effectiveness of budesonide/formoterol and fluticasone propionate/salmeterol in a 1-year, population-based, matched cohort study of patients with chronic obstructive pulmonary disease (COPD): effect on COPD-related exacerbations, emergency department visits and hospitalizations, medication utilization, and treatment adherenceClin Ther2010321320132820678680
- BaronJABarrettJUtility and limitations of claims dataAnn Intern Med199412010498185141
- GreenJUtility and limitations of claims dataAnn Intern Med1994120105010518018199
- HuffEDUtility and limitations of claims dataAnn Intern Med199412010498185142
- ProchazkaAVUtility and limitations of claims dataAnn Intern Med199412010508185143
- StromBLData validity issues in using claims dataPharmacoepidemiol Drug Saf20011038939211802582
- RamseySDScogginsJFBloughDKMcDermottCLReyesCMSensitivity of administrative claims to identify incident cases of lung cancer: a comparison of 3 health plansJ Manag Care Pharm20091565966819803555
- RileyGFAdministrative and claims records as sources of health care cost dataMed Care200947S51S5519536019